Review



polyclonal rabbit anti human myd88 abs  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc polyclonal rabbit anti human myd88 abs
    Expression of TLR4 and <t> MyD88 </t> in ovarian cancer, benign tumors and normal controls <xref ref-type= a " width="250" height="auto" />
    Polyclonal Rabbit Anti Human Myd88 Abs, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 495 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti human myd88 abs/product/Cell Signaling Technology Inc
    Average 96 stars, based on 495 article reviews
    polyclonal rabbit anti human myd88 abs - by Bioz Stars, 2026-06
    96/100 stars

    Images

    1) Product Images from "TLR4 signaling induced by lipopolysacharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer"

    Article Title: TLR4 signaling induced by lipopolysacharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer

    Journal: Oncogene

    doi: 10.1038/onc.2009.289

    Expression of TLR4 and MyD88 in ovarian cancer, benign tumors and normal controls <xref ref-type= a " title="Expression of TLR4 and MyD88 in ovarian cancer, benign tumors and ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Expression of TLR4 and MyD88 in ovarian cancer, benign tumors and normal controls a

    Techniques Used: Expressing

    A ) Immunostaining for TLR4 in a normal ovarian tissue adjacent to tumor (1), benign tumor (2), borderline tumor (3) and ovarian cancer ( Adenocarcionoma serosum FIGO III) (4) (Mag. × 200, Inset × 600); Immunostaining for MyD88 in ovarian tissues adjacent to tumor (5), benign tumor (6), borderline tumor (7), ovarian cancer ( Adenocarcionoma serosum FIGO III) (8) (Mag. × 200, Inset × 600. B ) Immunofluorescence for TLR4 protein in an ovarian cancer cell line (SKOV3) (2) Negative staining for TLR4 using isotype control IgG (1). Immunofluorescence for MyD88 in ovarian carcinoma cell lines, SKOV3 (3) and A2780 (4) (× 400); C ) Expression of TLR4 mRNA and Western blot for TLR4 and MyD88 in ovarian cancer cell lines.
    Figure Legend Snippet: A ) Immunostaining for TLR4 in a normal ovarian tissue adjacent to tumor (1), benign tumor (2), borderline tumor (3) and ovarian cancer ( Adenocarcionoma serosum FIGO III) (4) (Mag. × 200, Inset × 600); Immunostaining for MyD88 in ovarian tissues adjacent to tumor (5), benign tumor (6), borderline tumor (7), ovarian cancer ( Adenocarcionoma serosum FIGO III) (8) (Mag. × 200, Inset × 600. B ) Immunofluorescence for TLR4 protein in an ovarian cancer cell line (SKOV3) (2) Negative staining for TLR4 using isotype control IgG (1). Immunofluorescence for MyD88 in ovarian carcinoma cell lines, SKOV3 (3) and A2780 (4) (× 400); C ) Expression of TLR4 mRNA and Western blot for TLR4 and MyD88 in ovarian cancer cell lines.

    Techniques Used: Immunostaining, Immunofluorescence, Negative Staining, Control, Expressing, Western Blot



    Similar Products

    polyclonal rabbit anti human myd88 abs  (Cell Signaling Technology Inc)
    96
    Cell Signaling Technology Inc polyclonal rabbit anti human myd88 abs
    Expression of TLR4 and <t> MyD88 </t> in ovarian cancer, benign tumors and normal controls <xref ref-type= a " width="250" height="auto" />
    Polyclonal Rabbit Anti Human Myd88 Abs, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti human myd88 abs/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    polyclonal rabbit anti human myd88 abs - by Bioz Stars, 2026-06
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    Expression of TLR4 and MyD88 in ovarian cancer, benign tumors and normal controls <xref ref-type= a " width="100%" height="100%">

    Journal: Oncogene

    Article Title: TLR4 signaling induced by lipopolysacharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer

    doi: 10.1038/onc.2009.289

    Figure Lengend Snippet: Expression of TLR4 and MyD88 in ovarian cancer, benign tumors and normal controls a

    Article Snippet: Tumor cells deposited on glass slides were fixed in 2% (w/v) paraformaldehyde in PBS for 15 min, permeablized with 0.1% (w/v) Triton X in PBS, washed and blocked with 2% (w/v) bovine serum albumin (BSA; Sigma) in PBS for 4 min. Polyclonal goat anti-human TLR4 antibodies (Abs) (Santa Cruz Biotechnology; 1:100) or polyclonal rabbit anti-human MyD88 Abs (Cell Signaling Technology; 1:100) served as primary reagents.

    Techniques: Expressing

    A ) Immunostaining for TLR4 in a normal ovarian tissue adjacent to tumor (1), benign tumor (2), borderline tumor (3) and ovarian cancer ( Adenocarcionoma serosum FIGO III) (4) (Mag. × 200, Inset × 600); Immunostaining for MyD88 in ovarian tissues adjacent to tumor (5), benign tumor (6), borderline tumor (7), ovarian cancer ( Adenocarcionoma serosum FIGO III) (8) (Mag. × 200, Inset × 600. B ) Immunofluorescence for TLR4 protein in an ovarian cancer cell line (SKOV3) (2) Negative staining for TLR4 using isotype control IgG (1). Immunofluorescence for MyD88 in ovarian carcinoma cell lines, SKOV3 (3) and A2780 (4) (× 400); C ) Expression of TLR4 mRNA and Western blot for TLR4 and MyD88 in ovarian cancer cell lines.

    Journal: Oncogene

    Article Title: TLR4 signaling induced by lipopolysacharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer

    doi: 10.1038/onc.2009.289

    Figure Lengend Snippet: A ) Immunostaining for TLR4 in a normal ovarian tissue adjacent to tumor (1), benign tumor (2), borderline tumor (3) and ovarian cancer ( Adenocarcionoma serosum FIGO III) (4) (Mag. × 200, Inset × 600); Immunostaining for MyD88 in ovarian tissues adjacent to tumor (5), benign tumor (6), borderline tumor (7), ovarian cancer ( Adenocarcionoma serosum FIGO III) (8) (Mag. × 200, Inset × 600. B ) Immunofluorescence for TLR4 protein in an ovarian cancer cell line (SKOV3) (2) Negative staining for TLR4 using isotype control IgG (1). Immunofluorescence for MyD88 in ovarian carcinoma cell lines, SKOV3 (3) and A2780 (4) (× 400); C ) Expression of TLR4 mRNA and Western blot for TLR4 and MyD88 in ovarian cancer cell lines.

    Article Snippet: Tumor cells deposited on glass slides were fixed in 2% (w/v) paraformaldehyde in PBS for 15 min, permeablized with 0.1% (w/v) Triton X in PBS, washed and blocked with 2% (w/v) bovine serum albumin (BSA; Sigma) in PBS for 4 min. Polyclonal goat anti-human TLR4 antibodies (Abs) (Santa Cruz Biotechnology; 1:100) or polyclonal rabbit anti-human MyD88 Abs (Cell Signaling Technology; 1:100) served as primary reagents.

    Techniques: Immunostaining, Immunofluorescence, Negative Staining, Control, Expressing, Western Blot